Vimarsana
Biggest News Aggregation in the World

Page 14 - Cell Pouch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Pouch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Pouch Today - Breaking & Trending Today

Investegate |Sernova Corp. Announcements | Sernova Corp.: Sernova Announces Collaboration Agreements with Multiple Pharmaceutical Industry Leaders - Vimarsana News

Investegate |Sernova Corp. Announcements | Sernova Corp.: Sernova Announces Collaboration Agreements with Multiple Pharmaceutical Industry Leaders

DGAP-News: Sernova Corp. / Key word(s): Contract/Alliance Sernova Announces Collaboration Agreements with Multiple Pharmaceutical Industry Leaders 28.01.2021 / 14:10 Sernova Announces Collaboration Agreements with Multiple Pharmaceutical Industry Leaders Sernova's Cell Pouch platform and cell therapy expertise being used in multiple collaborations with global pharmaceutical companies LONDON, ONTARIO - January 28, 2021 - Sernova Corp. (TSX-V: SVA)(OTCQB: SEOVF)(FSE: PSH), a leading clinical-stage regenerative medicine therapeutics company, announced today that it has entered into multiple re...

Investors flock to Canadian device maker Sernova hoping to transform how diabetes is treated - Vimarsana News

Investors flock to Canadian device maker Sernova hoping to transform how diabetes is treated

The Globe and Mail Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account Getting audio file ... This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer Geoff Robins/The Globe and Mail A tiny London, Ont., medical device company hoping to change how diabetes is treated has had a wild ride of late. Last Friday, stock in Sernova Corp. shot up 65 per cent on the TSX Venture Exchange, then nearly doubled on Monday, closing at $2.42 a share. At its peak, Sernova had a market capitali...